| pubmed-article:20361534 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0206435 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0032371 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0005775 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0080194 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0282688 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C1551362 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C0035826 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C1999244 | lld:lifeskim |
| pubmed-article:20361534 | lifeskim:mentions | umls-concept:C2348867 | lld:lifeskim |
| pubmed-article:20361534 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20361534 | pubmed:dateCreated | 2010-4-5 | lld:pubmed |
| pubmed-article:20361534 | pubmed:abstractText | Until 2008 in Romania poliomyelitis has been controlled by predominantly using trivalent oral poliovirus vaccine (TOPV). The alternative vaccination schedule (formalin inactivated poliovirus vaccine IPV/OPV) has been implemented starting September 2008 and at the begining of 2009 was decided only vaccination with IPV. Between 1995-2006 the risk of the vaccine-associated paralytic poliomyelitis (VAPP) decreased with an average of less than 2 VAPP cases/year and no VAPP case between 2007 - September 2009. Begining with 2007 the number of the poliovirus strains isolated was less. All 9 poliovirus strains (PV) isolated between 2007-2009 and investigated by RT-PCR-RFLP in VP1-2A and VP3-VP1 coding regions showed Sabin-like profiles, and only one strain poliovirus type 3 showed Sabin 2-like profile by RFLP in 3D coding ARN polymerase region. The study about the seroprevalence of antibodies against poliovirus types in serum samples from the acute flaccid paralysis (AFP), facial paralysis (FP) cases showed that the seroprevalence of antibodies against types 1 and 2 Sabin strains was higher (>90%) than for type 3 Sabin strains (average 85%). It was confirmed the necessity of maintaining a proper vaccine coverage in population, after the switch in the vaccination strategy in Romania until all threats of poliovirus are eliminated globally. | lld:pubmed |
| pubmed-article:20361534 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20361534 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20361534 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20361534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20361534 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20361534 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20361534 | pubmed:issn | 1222-3891 | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:JASOVSKYXX | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:B?icu?AndaA | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:PersuAnaA | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:Opri?anGabrie... | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:PopescuMariaM | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:SzmalCameliaC | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:PenciuAlinaA | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:SoareAlinaA | lld:pubmed |
| pubmed-article:20361534 | pubmed:author | pubmed-author:GrecuNicolaeN | lld:pubmed |
| pubmed-article:20361534 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20361534 | pubmed:volume | 68 | lld:pubmed |
| pubmed-article:20361534 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20361534 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20361534 | pubmed:pagination | 145-50 | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:meshHeading | pubmed-meshheading:20361534... | lld:pubmed |
| pubmed-article:20361534 | pubmed:articleTitle | Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy. | lld:pubmed |
| pubmed-article:20361534 | pubmed:affiliation | National Institute of Research and Development for Microbiology and Immunology Cantacuzino, Bucharest, Romania. abaicus@cantacuzino.ro | lld:pubmed |
| pubmed-article:20361534 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20361534 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
